Transaction · 0001304492-24-000012

Kuhn Thomas R.

Kuhn Thomas R., DIR, reported a transaction classified as grant at Anterix Inc. involving 58998.000000 shares for an estimated $0.00. Reported holdings after the transaction were 58998.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ADIR
ATEXAnterix Inc.
Filing timeJan 04
Trade dateJan 02, 2024
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

ATEX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
ATEX since 2024-01-04Filed 973 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001304492-24-000012
Stock Option (Right to Buy)
Transaction date
Jan 02, 2024
Filed Jan 04, 2024, 05:52 PM · 2d delay
Shares
58.9k sh
$0 per share
Estimated value
$0
Computed from shares × price
Holdings after
58.9k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Derivative Transaction Direct Ownership Large Holdings Increase
-6score
Filing-only score

-6

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther Yes
Footnotes & amended
  1. F1

    The restricted stock vests in full on August 7, 2024.

  2. F2

    Options awarded in connection with director's appointment to the Board as Vice Chairman. For further information see the Anterix Inc. Form 8-K filed with the Securities Exchange Commission on January…

  3. F3

    1/3rd of the option shares vest and become exercisable on January 2, 2025, with the remaining option shares vesting in 2 equal annual installments thereafter.

Original filing · 0001304492-24-000012
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

ATEX